Targeted Therapies and Companion Diagnostic Tests. From development to “market access” Targeted Therapies and Companion Diagnostic Tests. From Development to “Market Access”.
Jan
12,
2021
-
Jan
14,
2021
January 12 & 14, 2021
Overview:
- Understand the definitions and regulatory framework governing these products. Impact of new European DM regulations and DMDIV.
- How to proceed with the analytical validation.
- How to demonstrate clinical validity and prove clinical utility.
- What development strategy to adopt?.
And much more. Click here for more details.